Background Inadequate myocardial tissue perfusion after successful revascularization in ST-segment elevation myocardial infarction (STEMI) is associated with worse clinical outcomes. We investigated whether the plasma B-type natriuretic peptide (BNP) level on admission could predict the status of myocardial tissue perfusion in patients who underwent primary percutaneous coronary intervention (PCI).
Methods
The study prospectively enrolled 102 patients with STEMI who underwent primary PCI within 12 h of symptom onset. The grade of myocardial tissue perfusion was measured by ST-segment resolution, corrected thrombolysis in myocardial infarction frame count, and myocardial blush grade after primary PCI. All-cause mortality at 1 month after PCI was assessed.
Results All patients were divided into two groups according to the BNP level; high-BNP group (Z 80 pg/ml, n = 43) and low-BNP group (< 80 pg/ml, n = 59). High-BNP group had significantly lower ST-segment resolution (42.69 ± 24.85 vs. 71.15 ± 19.37%, P < 0.001), higher corrected thrombolysis in myocardial infarction frame count (53.7 ± 19.7 vs. 44.5 ± 15.5, P = 0.04), lower myocardial blush grade (2.4 ± 0.9 vs. 2.9 ± 0.3, P = 0.001), and higher short-term mortality (16.2 vs. 3.3%, P = 0.023). In multivariate logistic regression analysis for prediction of good myocardial tissue perfusion after PCI, the odds ratio of low-BNP group was 4.12 (95% confidence interval 1.49-13.08, P < 0.01).
Conclusion
The patients with STEMI who had higher BNP level on admission showed inadequate myocardial tissue perfusion status after primary PCI. The plasma BNP level on admission may serve as a predictor of tissue perfusion after primary PCI in patients with STEMI. 
Introduction
Early restoration of normalized coronary flow is the main therapeutic objective in patients with ST-segment elevation myocardial infarction (STEMI), which reduces infarct size, left ventricular dysfunction, and mortality [1] . Despite normalized epicardial coronary flow after reperfusion therapy in patients with STEMI, a substantial proportion of patients fail to achieve successful myocardial tissue perfusion, which is associated with adverse clinical outcomes [2, 3] . B-type natriuretic peptide (BNP) is released from the cardiac ventricles in response to increased wall stress. Elevated initial plasma BNP levels in patients with STEMI have been reported to be associated with incomplete resolution of ST-segment elevation and impaired epicardial coronary flow in subsequent angiogram after fibrinolytic therapy and to predict higher short-term mortality [4, 5] .
Primary percutaneous coronary intervention (PCI) with the use of stents has become the standard management of patients with STEMI [6] . Primary PCI using stent has improved short-term and long-term clinical outcomes compared with fibrinolytic therapy, because primary PCI provides a greater chance of getting normalized epicardial coronary perfusion [thrombolysis in myocardial infarction (TIMI) flow grade II or III] than fibrinolytic therapy [6, 7] . However, inadequate tissue perfusion and no-reflow phenomenon after primary PCI are still a problem in the era of the drug-eluting stent (DES), which are related to worse clinical outcomes such as death, development of heart failure, or ventricular arrhythmia. Thus, it is still needed to find predictors of subsequent impaired tissue reperfusion after primary PCI in patients with STEMI.
In this study, we investigated whether the initial plasma BNP levels could predict the status of myocardial tissue perfusion and short-term mortality in patients with STEMI who were treated with primary PCI using DES and achieved normalized epicardial coronary flow.
Methods

Study patients
The study population consisted of 102 patients with acute STEMI who were treated with primary PCI using DES at Uijeongbu St. Mary's Hospital from July 2005 to July 2006. All patients achieved TIMI flow grade II or III in their culprit coronary arteries after primary PCI. The study protocol was reviewed and approved by the institutional review boards. Written informed consent was obtained from all patients before the procedure. Eligible patients for this study were over 20 years of age, had ST-segment elevation of at least 0.1 mV in at least two consecutive leads in the electrocardiogram, visited hospital within 12 h after development of chest pain, and had a door-to-balloon time within 90 min.
The criteria for exclusion included failure to achieve TIMI flow II or III after primary PCI, a history of congestive heart failure, chronic renal disease, earlier myocardial infarction, a history undergoing coronary artery bypass surgery or PCI, non-ST-segment elevation acute coronary syndrome, door-to-balloon time over 90 min, and malignancy.
Percutaneous coronary intervention procedure and medical treatment
Diagnostic angiography and PCI were performed after administration of 300 mg aspirin, 600 mg clopidogrel, and 10 000 IU unfractionated heparin. Coronary angiography was performed through the femoral artery. During the procedure, patients received unfractionated heparin to maintain an activated clotting time of 250 s. Stents were deployed after balloon angioplasty. The administration of platelet glycoprotein IIb/IIIa receptor blockers and the use of thrombus aspiration and intra-aortic balloon pulsation were left to the decision of the individual operator. A successful PCI procedure was defined as the achievement of an angiographic minimum stenosis diameter reduction to less than 30% in the presence of TIMI grade II or III flow.
During the in-hospital period, patients received medical treatment that included aspirin, clopidogrel, statin, bblockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and/or calcium channel blockers. Dual antiplatelet therapy was administered to all patients. After discharge, the patients kept on the same medications that they had received during the hospital stay except for some intravenous or temporary medications.
Assessment of biomarkers
Blood sampling for the measurement of serum biomarkers was done in the emergency room before PCI. Measured biomarkers included BNP, high-sensitivity C-reactive protein (hsCRP), and troponin-T. BNP level was measured by a fluorescent immunoassay method using the Triage BNP Test (Biosite Incorporated, San Diego, California, USA) [8] . The measuring range provided by the manufacturer, which was defined by the lower detection limit and the maximum of the master curve, is 1-5000 pg/ml. The hsCRP was measured by an immunonephelometric assay (Hitachi High Technologies Co., Tokyo, Japan) with a decision limit of 0.3 mg/dl. Troponin-T was measured using the Elecsys 2010 (Roche Diagnostics GmbH, Mannheim, Germany) with a decision limit of 0.1 ng/ml.
Study definition and clinical analysis
Baseline demographics, clinical history, and objective assessment of clinical signs were obtained by trained cardiologists. The records of cardiovascular risk factors and history (age, sex, hypertension, dyslipidemia, smoking, diabetes mellitus, and earlier ischemic heart disease) were mainly dependent on patients' self-report. However, the final records were left to the physician's discretion after he or she comprehensively considered the patient's self-report and the in-hospital examination results.
Coronary angiographies were reviewed by two experienced interventional cardiologists blinded to BNP results. Disagreements between the two readers were solved by consensus reached with subsequent joint evaluation of the angiographic findings. Coronary blood flow patterns before and after primary PCI were assessed according to the TIMI flow scale, using grade 0, I, II, and III [9] . Myocardial tissue reperfusion was categorized by the STsegment resolution (STR) at 120 min after primary PCI, corrected TIMI frame count (CTFC), and myocardial blush grade (MBG). The 12-lead electrocardiograms were obtained immediately before and 120 min after PCI. Using a caliper, the degree of ST-segment elevation was assessed at the J-point of each lead from the isoelectric line (excluding augmented vector right). The degree of STR was assessed by converting the difference of the sum of ST-segment elevation in all leads before and after PCI into a percentage [10] . The complete STR was defined as a resolution rate of at least 70%. The CTFC was the number of cine frames required for the contrast dye to first reach the standardized distal coronary landmarks in the infarct-related artery and was measured by use of a frame counter on a cine viewer [11] . A filming speed of angiograms was 30 frames per second. MBG was assessed according to the dye density score proposed by Van't Hof et al. [12] in patients with primary PCI, from 0 (no contrast density or abnormal persistence of contrast medium) to 3 (normal contrast density relatively to the dye density in uninvolved areas).
Good myocardial tissue perfusion was defined as MBG 2 or 3 and STR more than or equal to 70% [13, 14] . Allcause mortality was evaluated at 1 month after the PCI procedure.
Statistical analysis
The BNP level was dichotomized using a cutoff value which is calculated by the receiver operating characteristics (ROC) curve. The baseline characteristics of patients with high and low BNP were compared using the t-test or the Wilcoxon rank sum test for continuous variables and the w 2 test for categorical variables. The association between each biomarker and clinical outcomes was evaluated using the w 2 or Fisher exact test for dichotomized comparisons. ROC curve analysis of cardiac markers was performed to identify the optimal cutoff value for predicting the myocardial tissue perfusion. Multivariate analysis using logistic regression adjusting clinical and angiographic variables as covariates was performed to identify determinants of myocardial tissue perfusion and 1 month mortality. A P value of less than 0.05 was required for the statistical significance. All statistical analyses were done with SPSS 15.0 (SPSS-PC Inc., Chicago, Illinois, USA).
Results
Baseline characteristics
A total of 102 patients who presented with the first STEMI and were treated with primary PCI entered the study. Average age of the patients was 63.3 ± 11.0 years (range, 37-86 years) and the proportion of male individuals was 65.7% (n = 67). Serum BNP levels ranged from 5 to 253 pg/ml and have mean value of 82.8 ± 69.7 pg/ml and a median of 61.5 pg/ml. Table 1 shows the baseline characteristics of patients with higher BNP levels (high-BNP group, Z80 pg/ml, n = 43) and lower BNP levels (low-BNP group, < 80 pg/ml, n = 59). There were no differences in demographic characteristics between two groups. High-BNP group showed significantly higher troponin T (3.0 ± 4.3 vs. 1.2 ± 0.4 ng/ml, P < 0.001) and higher hsCRP level on admission (5.2 ± 5.1 vs. 1.4 ± 1.5 mg/dl, P < 0.001).
Predictive value of cardiac biomarkers
ROC curve analysis was performed to assess the predictive power of cardiac markers for the myocardial tissue perfusion. The area under the ROC curve for BNP was 0.645 ( Fig. 1) . A BNP level of higher than 78 pg/ml had a sensitivity of 81.6% and a specificity of 56.2% for predicting the myocardial tissue perfusion. The area under the ROC curves for CRP, creatine kinase-MB, and troponin T were relatively low, 0.554, 0.509, and 0.522, respectively.
Angiographic and electrocardiographic observation
There were no differences in angiographic characteristics between two groups ( Table 2) . Table 3 shows the myocardial tissue perfusion assessments. High-BNP group is more likely to have higher CTFC and lower MBG compared with low-BNP group. In addition, high-BNP group has lower STR and higher incomplete resolution of ST-segment. As a result, low-BNP group had higher rate of good myocardial tissue perfusion compared with high-BNP group. In multivariate logistic regression analysis, BNP level at presentation was an independent predictor of good myocardial tissue perfusion after PCI (Table 4 ).
Plasma BNP level and short-term mortality after PCI
A total of nine (8.8%) patients died within 1 month after PCI. The patients with BNP of higher than 80 pg/ml had higher mortality at 1 month after PCI (16.2 vs. 3.3%, P = 0.023). In multivariate Cox regression analysis, the BNP level at presentation was an independent risk factor for mortality at 1 month after PCI (Table 5 ).
Discussion
This study demonstrates that initial BNP level on admission can predict the status of myocardial tissue perfusion after primary PCI and all-cause mortality at 1 month in patients with STEMI. STEMI patients with higher plasma BNP levels (Z 80 pg/ml) show higher CTFG and lower MBG and STR after optimal primary PCI, which were reflective of reduced myocardial tissue perfusion.
Recent studies have demonstrated that reduced myocardial tissue perfusion is a marker of more extensive myocardial tissue damage and has been proven to be associated with poorer functional recovery, an increased frequency of heart failure, and poor survival in patients with acute myocardial infarction [15, 16] . This is why there is a growing need to establish a reliable marker to predict adequate myocardial tissue perfusion after optimal primary PCI in the setting of STEMI. Several tools to evaluate myocardial tissue perfusion have been proposed, which include electrocardiographic (STR) and angiographic methods (CTFC and MBG). Although these tools are simple and practical as a method to evaluate myocardial tissue perfusion in patients with STEMI after emergency revascularization is done, predictable biomarkers that give information on myocardial tissue perfusion before primary PCI are needed in real practice.
The elevation of plasma BNP level in patients with acute myocardial infarction (AMI) reflects left ventricular dysfunction during ischemia and is directly proportional to the amount of myocardium in jeopardy [17] [18] [19] . The plasma BNP levels in patients with AMI are also associated with anatomic severity of coronary artery disease, including the number of diseased vessels and involvement of the proximal left anterior descending artery [20] [21] [22] . As the magnitude of the ischemic insult and long-term prognosis is well known, the plasma BNP level may remain an important prognostic biomarker in patients with AMI [23] . In addition, the plasma BNP level is particularly predictive of mortality, probably because an elevated BNP level reflects a larger infarct size, progressive left ventricular remodeling, and thus a more pronounced degree of myocardial dysfunction [24] .
In our study, there were no differences in the number of diseased vessels, involvement of the left anterior descending artery, and left ventricular ejection fraction between the two groups. Thus, the difference in the BNP level may reflect transient depression of left ventricular function resulting from infarct-associated regional wall stress, local ischemia, hypoxia, acidosis, increased level of catecholamines, and increased activity of the renin-angiotensin-aldosterone system [25] [26] [27] [28] [29] .
Two major impediments to normalization of myocardial tissue perfusion are microvascular damage due to platelet microemboli and thrombi, and reperfusion injury after primary PCI [30, 31] . The failure of optimal myocardial tissue perfusion after primary PCI identifies patients with a higher risk of LV dysfunction and mortality, presumably because of microvascular damage in the infarct zone, despite normalized epicardial coronary artery flow. Subclinical heart failure in patients with STEMI which can be identified by elevated plasma BNP levels may imply that infracted coronary beds lose the ability to clear or wash out microthromboemboli due to microvascular damage [32] . Reperfusion injury gives rise to cellular edema, endothelial disruption, plugging of capillaries by neutrophils and microthrombi, free radical formation, complement activation, and contracture of neighboring myocytes [33] . The elevated plasma BNP level is associated with reperfusion injury in some case of cardiac transplantation, providing evidence to support its potential use as a reperfusion injury [34] .
We have several limitations. First, a relatively small number of patients was enrolled. Second, this study is a single-center study and thus it is difficult to be generalized. Third, although this study shows interesting results on the association of the plasma BNP levels with myocardial tissue perfusion status, it does not provide direct insight into the underlying pathobiology. Fourth, this study has lack of data that patients take the medication such as statin, antiangina drug, and angiotensin-receptor blocker or angiotensin-converting enzyme inhibitor before admission, which may affects myocardial tissue perfusion. Fifth, no-reflow phenomenon has low TIMI flow after primary PCI was excluded, which seriously affect myocardial tissue perfusion. The potential interaction between BNP level and myocardial tissue perfusion after PCI needs additional study.
Conclusion
This study demonstrates that the plasma BNP level on admission can identify high-risk groups with impaired myocardial tissue perfusion, in the setting of primary PCI in patients with STEMI.
